Akebia Therapeutics Inc (NAS:AKBA)
$ 0.89 +0.027 (+3.11%) Market Cap: 247.51 Mil Enterprise Value: 146.93 Mil PE Ratio: 0 PB Ratio: 9.71 GF Score: 47/100

Akebia Therapeutics Inc (AKBA) Transcripts

  • 1